Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis

Diabetes Care

Volumn 29, Issue 10, 2006, Pages 2196-2199

  Sämann, Alexander ^a   Mühlhauser, Ingrid ^b   Bender, Ralf ^c   Hunger Dathe, Wilgard ^a   Kloos, Christof ^a   Müller, Ulrich A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; ISOPHANE INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HEALTH EDUCATION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HUMANS; HYPOGLYCEMIA; INSULIN; PATIENT EDUCATION; RISK; SELF CARE; SODIUM OXYBATE;

EID: 33845447377     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0751     Document Type: Article

References (23)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial: the Diabetes Control and Complications Trial Research Group. Diabetes 46:271-286, 1997
3. Amiel SA: Type 1 diabetes: treatment without tears? Diabetologia 48:1963-1964, 2005
4. DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment for Normal Eating (DAFNE) randomised controlled trial. BMJ 325:746, 2002
5. Plank J, Kohler G, Rakovac I, Semlitsch BM, Horvath K, Bock G, Kraly B, Pieber TR: Long-term evaluation of a structured outpatient education program for intensified insulin therapy in patients with type 1 diabetes: a 12-year follow-up. Diabetologia 47:1370-1375, 2004
6. Sämann A, Mühlhauser I, Bender R, Kloos Ch, Müller UA: Glycemic control and severe hypoglycemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: prospective implementation study. Diabetologia 48:1965-1970, 2005
7. Mühlhauser I, Jörgens V, Berger M, Graninger W, Gürtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE: Bicentric evaluation of a teaching and treatment program for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25:470-476, 1983
8. Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu-Tirgoviste C, Scholz V, Mincu I: Evaluation of an intensified insulin treatment and teaching program as routine management of type 1 (insulin-dependent) diabetes: the Bucharest-Dusseldorf Study. Diabetologia 30: 681-690, 1987
9. Starostina EG, Antsiferov M, Galstyan GR, Trautner C, Jörgens V, Bott U, Mühlhauser I, Berger M, Dedov II: Effectiveness and cost-benefit analysis of intensive treatment and teaching programs for type 1 (insulin-dependent) diabetes mellitus in Moscow: blood glucose versus urine glucose self-monitoring. Diabetologia 37:170-176, 1994
10. Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M: Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 36:99-105, 1993
11. Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ: Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18:625-630, 1995
12. Mühlhauser I, Bott U, Overmann H, Wagener W, Bender R, Jörgens V, Berger M: Liberalized diet in patients with type 1 diabetes. J Intern Med 237:591-597, 1995
13. Mühlhauser I, Berger M: Patient education: evaluation of a complex intervention. Diabetologia 45:1723-1733, 2002
14. Müller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jörgens V, Berger M, Mühlhauser I: Intensified treatment and education of type 1 diabetes as clinical routine: a nationwide quality-circle experience in Germany: ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 22 (Suppl. 2):B29-B34, 1999
15. Cox DJ, Kovatchev B, Koev D, Koeva L, Dachev S, Tcharaktchiev D, Protopopova A, Gonder-Frederick L, Clarke W: Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med 11:212-218, 2004
16. Schachinger H, Hegar K, Hermanns N, Straumann M, Keller U, Fehm-Wolfsdorf G, Berger W, Cox D: Randomized controlled clinical trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany. J Behav Med 28:587-594, 2005
17. Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W: Blood Glucose Awareness Training (BGAT-2): long-term benefits. Diabetes Care 20:637-642, 2001
18. Fukuda M, Tanaka A, Tahara Y, Ikegami H, Yamamoto Y, Kumahara Y, Shima K: Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control. Diabetes 37:81-88, 1988
19. DCCT Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65:30-36, 1987
20. Gonder-Frederick L, Cox D, Kovatchev B, Schlundt D, Clarke W: A biopsycho-behavioral model of risk of severe hypoglycemia. Diabetes Care 20:661-669, 1997
21. Laing SP, Jones ME, Swerdlow AJ, Burden AC, Gatling W: Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes. Diabetes Care 28:1618-1623, 2005
22. Jacqueminet S, Masseboeuf N, Rolland M, Grimaldi A, Sachon C: Limitations of the so-called "intensified" insulin therapy in type 1 diabetes mellitus. Diabetes Metab 31:4S45-4S50, 2005
23. Bott S, Bott U, Berger M, Mühlhauser I: Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia 40:926-932, 1997